People

The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

 

Jason Satterfield, PhD, MA

Professor of Clinical Medicine
Medicine

Jason M. Satterfield is past Academy Endowed Chair for Innovation in Teaching, Director of Behavioral Medicine and Professor of Clinical Medicine in the Division of General Internal Medicine at the University of California San Francisco. He received his B.S. in brain sciences from MIT and his Ph.D. in clinical psychology from the University of Pennsylvania. Dr.

Suzaynn Schick, PhD

Associate Professor
Medicine

I study the health effects of air pollution in human subjects. I focus on the chemistry and toxicity of smoke and on how exposure to tobacco or cannabis smoke can cause heart and lung disease. My analysis of tobacco industry research showed that sidestream cigarette smoke (the primary constituent of secondhand cigarette smoke) is more toxic than the smoke that smokers inhale and that secondhand smoke becomes more toxic as it ages.

Laura Schmidt, PhD, MSW, MPH

Professor in Residence
Institute for Health Policy Studies

My lab investigates the societal root causes of chronic disease in our current food system. We study the interplay between the processed food industry and the populations that experience health harms from its products. Our research informs new ways to prevent obesity, diabetes, and related cardiometabolic diseases by making food systems more conducive to health.

Steve Schroeder, MD

Professor
Medicine

Dr. Schroeder is Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers.

Mark Schumacher, MD, PhD

Professor
Anesthesia

Dr. Schumacher is Professor and Vice Chair of Pain Medicine in the Department of Anesthesia and Perioperative Care, University of California, San Francisco. He has a clinical, research and educational focus on pain medicine with an emphasis on the development of evidence – based pain care into general clinical practice that utilize non-addictive modalities to improve both the quality and safety of analgesic care. Dr.

Joel Simon, MD, MPH

Professor Emeritus
Medicine

Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation.    Dr.

Neiloy Sircar, JD, LLM

Access Extension

Neil Sircar, JD, LLM is a human rights lawyer specializing in global and public health, global governance, and health in humanitarian crises. He recently concluded a Fogarty Global Health Fellowship with the National Institutes for Health through the Northern Pacific Global Health Consortium at the University of Washington. He is principal investigator on a study for assessing the implementation of human rights-based approaches to HIV testing and notification in Kenya with the prominent Kenyan non-governmental organization Kenya Legal and Ethical Issues Network.

Elizabeth Smith, PhD

Professor

Dr. Smith's work focuses on tobacco control policy, particularly approaches to the tobacco endgame. Past projects include work on the tobacco industry's influence on and relationships with the lesbian, gay, bisexual and transgender communities, tobacco industry interest in diet and obesity issues, tobacco product waste and pollution, and tobacco control policy issues in the U.S. military.

Joanne Spetz, PhD

Professor

Joanne Spetz is Director and Brenda and Jeffrey L. Kang Presidential Chair in Health Care Financing at the Philip R. Lee Institute for Health Policy Studies (IHPS), University of California San Francisco. IHPS is a 50-year-old organization that conducts innovative research to support, guide, and enable policymakers, communities, and clinicians in making evidence-informed decisions that improve health and health care for individuals and families.

Matt Springer, PhD

Professor
Medicine

RESEARCH INTERESTS:

Gideon St Helen, PhD

Assistant Professor
Medicine

The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.

Research Themes Visual- information below

Hugh Sturrock, PhD

ASSOC ADJ PROF-HCOMP

Pages